Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX

Goldman Sachs Group Inc reported a 5.20% stake in Syndax Pharmaceuticals, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 9, 2025

Goldman Sachs Group Inc reported a 5.20% stake in Syndax Pharmaceuticals, Inc., 4,510,669 shares, as a passive investor on Mar 31, 2025. Filed May 9, 2025 (Schedule 13G/A).

Stake
5.20%
Shares
4,510,669
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
THE GOLDMAN SACHS GROUP, INC.5.20%4,510,669
GOLDMAN SACHS & CO. LLC5.20%4,510,669

Source

View original at SEC

Related